Shiller PE for Stocks: The True Measure of Stock Valuation
IPI Legacy Liquidation Co Cyclically Adjusted Price-to-FCF Historical Data
The historical data trend for IPI Legacy Liquidation Co's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
IPI Legacy Liquidation Co Cyclically Adjusted Price-to-FCF Chart
Competitive Comparison of IPI Legacy Liquidation Co's Cyclically Adjusted Price-to-FCF
For the Biotechnology subindustry, IPI Legacy Liquidation Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IPI Legacy Liquidation Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IPI Legacy Liquidation Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where IPI Legacy Liquidation Co's Cyclically Adjusted Price-to-FCF falls into.
IPI Legacy Liquidation Co Cyclically Adjusted Price-to-FCF Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
IPI Legacy Liquidation Co does not have a history long enough to calculate Cyclically Adjusted FCF per Share. Therefore GuruFocus does not calculate Cyclically Adjusted Price-to-FCF for this company.
IPI Legacy Liquidation Co (OTCPK:IMPLQ) Cyclically Adjusted Price-to-FCF Explanation
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
IPI Legacy Liquidation Co Cyclically Adjusted Price-to-FCF Related Terms
Thank you for viewing the detailed overview of IPI Legacy Liquidation Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
IPI Legacy Liquidation Co (IPI Legacy Liquidation Co) Business Description
Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IMPLQ has been successfully added to your 